Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $4.05 per share for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2023-08-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2023-06-30 | $4.05 6-K · filed 2023-08-31 | |
| 2022-12-31 | $0.54 20-F · filed 2023-03-30 | |
| 2021-12-31 | $1.00 20-F · filed 2022-03-24 | |
| 2019-12-31 | $5.98 20-F · filed 2021-03-25 | |
| 2018-12-31 | $7.53 20-F · filed 2021-03-25 |